MCGI, in collaboration with JAX’s Clinical Education Program, provides education to help clinicians integrate the use of large-scale tumor genomic testing into practice.
MCGI provides access to:
The MCGI Genomic Tumor Board, a virtual case conference, facilitates collaboration between oncology clinicians and pathology and genomic experts to prioritize treatment options based on genomic tumor test results.Learn more
The MCGI Forum occurs annually in a hybrid format. It includes education sessions on genomic tumor testing and targeted treatments, updates about MCGI data, and opportunities to network with colleagues and JAX leadership.Learn more
Online, interactive CME/CNE modules provide the opportunity for oncology providers to learn or refresh their understanding of clinical issues related to genomics in cancer. There are modules on topics such as choosing the best genomic tumor testing (CME | CNE) and indications for germline testing after genomic tumor testing (CME | CNE). See the entire catalog of offerings.Learn more
Short and targeted online resources address a specific aspect of the role of genomics in cancer care. The topics include information about specific targeted treatments (e.g., PARP inhibitors), communicating with patients about shared decision making, and testing to identify genomic variants related to cancer, among many others. See the entire catalog of offerings.Learn more
JAX's clinical education team develops MCGI materials through collaboration with practicing oncologists and genomic experts.
Read about the Maine Cancer Foundation’s gift to advance genomics education through MCGI here.
Do you have questions about education or suggestions for new MCGI resources? Contact us at MCGI@jax.org.